Internationalmarket entryfor health innovation.
HealthSeed is a Swiss healthcare venture studio. We help biotech, medtech, diagnostics and digital-health companies launch and scale across Europe, North America, and MENA with senior operators, an integrated specialist network, and pricing tied to your commercial outcomes.
Built by senior pharma operators. We bring experience in building brands, shaping markets, and achieving growth.
European healthcare innovation fails on commercial infrastructure, not science.
Europe's increasingly complex and fragmented regulatory environment has made it a less attractive region to invest, innovate, commercialise, and scale up. For companies building breakthrough diagnostics, digital therapeutics, and AI-powered clinical tools, that has a specific consequence. A region that ought to be among the most attractive markets in the world, with large patient populations, universal coverage, and a deep clinical research base, has become one of the hardest to enter.
Approval is only the first step into a sequence of national and local systems that each have to be worked separately: regulatory clearance granted country by country, reimbursement negotiated nation by nation, and procurement decided hospital by hospital. The time and capital required to move through that sequence rarely match what the European opportunity looks worth on paper, so capital, founders, and proven products increasingly route around Europe rather than into it. The companies that should be winning here often never arrive, and the patients who would benefit wait longest for innovations that already exist.
Four ways to partner with us.
Assess
Market feasibility, regulatory pathway analysis, and competitive positioning. Walk away with a board-grade, strategic roadmap that tells you exactly what EU entry requires, costs, and takes.
Assessment fee credits in full against a Launchpad engagement.
Learn more →Launch
Full European market entry. Regulatory, reimbursement, hospital pilots and commercial launch. One integrated programme to accelerate your market entry.
Scale
Already in Europe but stuck on a specific barrier? We deploy against your highest-priority bottleneck: reimbursement, hospital pilots, or commercial infrastructure.
Partner
Joint ventures, business-development mandates, equity-linked partnerships, or consortium design. We structure commercial partnerships, ecosystem building and AI/digital transformation from your needs.
HealthSeed is an operator-led commercialisation partner.
| HealthSeed | DIY | Boutique consultancy | Big 4 consultancy | Regulatory firm | |
|---|---|---|---|---|---|
| Operator depth | ✓ Senior execs (Pharma, Diagnostics, MedTech) | − Founder learning | ~ Mixed senior/junior | ~ Senior strategy, junior delivery | ✓ Deep but narrow |
| European breadth | ✓ 30+ markets via expert network | − Limited founder reach | ~ Strong in 1-3 markets | ✓ Broad but generic | ~ Country-specific specialists |
| Pricing model | ✓ Flexible Pricing + milestones + success fees | ✓ Internal cost only | −T&M, no outcome link | − Fixed fee, no outcome link | − Hourly rates |
| Success alignment | ✓ Up to 40% tied to outcomes | ✓ Full alignment | − None | − None | − None |
| Delivery integrated | ✓ Regulatory through revenue | ~ Founder coordinates fragments | ~ Limited scope | ~ Strategy decks, not execution | − Single function only |
Ready to explore your next market entry?
Book a 30-minute discovery call. We will discuss your product, your target markets, and whether HealthSeed is the right partner.